vs
Side-by-side financial comparison of Arbutus Biopharma Corp (ABUS) and Coda Octopus Group, Inc. (CODA). Click either name above to swap in a different company.
Arbutus Biopharma Corp is the larger business by last-quarter revenue ($10.7M vs $7.3M, roughly 1.5× Coda Octopus Group, Inc.). Arbutus Biopharma Corp runs the higher net margin — 23.5% vs 14.1%, a 9.4% gap on every dollar of revenue. On growth, Arbutus Biopharma Corp posted the faster year-over-year revenue change (522.2% vs 43.8%). Over the past eight quarters, Coda Octopus Group, Inc.'s revenue compounded faster (27.7% CAGR vs -13.2%).
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
CODA plc was a mid-sized international financial software company based in the United Kingdom. Founded in 1979, it was purchased in 2008 by Unit4, a supplier of enterprise software, based in the Netherlands. CODA creates, markets and implements a range of business software systems designed for finance directors and finance departments. These include:financial management systems like accounting software and procurement software: financial analysis applications like reporting, consolidation and...
ABUS vs CODA — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.7M | $7.3M |
| Net Profit | $2.5M | $1.0M |
| Gross Margin | — | 67.6% |
| Operating Margin | 13.9% | 19.3% |
| Net Margin | 23.5% | 14.1% |
| Revenue YoY | 522.2% | 43.8% |
| Net Profit YoY | 112.7% | 214.3% |
| EPS (diluted) | $0.01 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $7.3M | ||
| Q3 25 | — | $7.1M | ||
| Q2 25 | $10.7M | $7.0M | ||
| Q1 25 | — | $5.2M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | — | $5.5M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $4.5M |
| Q4 25 | — | $1.0M | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | $2.5M | $908.8K | ||
| Q1 25 | — | $913.0K | ||
| Q4 24 | — | $326.2K | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | — | $629.9K |
| Q4 25 | — | 67.6% | ||
| Q3 25 | — | 68.3% | ||
| Q2 25 | — | 64.1% | ||
| Q1 25 | — | 65.8% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 73.9% | ||
| Q2 24 | — | 70.2% | ||
| Q1 24 | — | 69.2% |
| Q4 25 | — | 19.3% | ||
| Q3 25 | — | 19.5% | ||
| Q2 25 | 13.9% | 15.5% | ||
| Q1 25 | — | 12.7% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 25.4% | ||
| Q1 24 | — | 12.4% |
| Q4 25 | — | 14.1% | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | 23.5% | 13.0% | ||
| Q1 25 | — | 17.5% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 23.3% | ||
| Q2 24 | — | 26.6% | ||
| Q1 24 | — | 14.1% |
| Q4 25 | — | $0.10 | ||
| Q3 25 | — | $0.11 | ||
| Q2 25 | $0.01 | $0.08 | ||
| Q1 25 | — | $0.08 | ||
| Q4 24 | — | $0.02 | ||
| Q3 24 | — | $0.11 | ||
| Q2 24 | — | $0.13 | ||
| Q1 24 | — | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $28.7M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $83.0M | $58.1M |
| Total Assets | $103.3M | $64.5M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $28.7M | ||
| Q3 25 | — | $26.2M | ||
| Q2 25 | $37.4M | $24.5M | ||
| Q1 25 | — | $22.5M | ||
| Q4 24 | — | $22.5M | ||
| Q3 24 | — | $25.2M | ||
| Q2 24 | — | $23.7M | ||
| Q1 24 | — | $25.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $58.1M | ||
| Q3 25 | — | $57.3M | ||
| Q2 25 | $83.0M | $55.9M | ||
| Q1 25 | — | $53.1M | ||
| Q4 24 | — | $53.1M | ||
| Q3 24 | — | $52.8M | ||
| Q2 24 | — | $51.1M | ||
| Q1 24 | — | $50.1M |
| Q4 25 | — | $64.5M | ||
| Q3 25 | — | $61.9M | ||
| Q2 25 | $103.3M | $60.6M | ||
| Q1 25 | — | $56.9M | ||
| Q4 24 | — | $57.5M | ||
| Q3 24 | — | $55.9M | ||
| Q2 24 | — | $54.0M | ||
| Q1 24 | — | $53.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $2.9M |
| Free Cash FlowOCF − Capex | — | $2.5M |
| FCF MarginFCF / Revenue | — | 34.9% |
| Capex IntensityCapex / Revenue | 0.0% | 5.0% |
| Cash ConversionOCF / Net Profit | -6.24× | 2.83× |
| TTM Free Cash FlowTrailing 4 quarters | — | $6.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.9M | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | $-15.7M | $1.5M | ||
| Q1 25 | — | $641.5K | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $-955.8K | ||
| Q1 24 | — | $-298.0K |
| Q4 25 | — | $2.5M | ||
| Q3 25 | — | $1.6M | ||
| Q2 25 | — | $1.4M | ||
| Q1 25 | — | $513.4K | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | — | $-1.1M | ||
| Q1 24 | — | $-433.6K |
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 22.6% | ||
| Q2 25 | — | 19.9% | ||
| Q1 25 | — | 9.9% | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 28.2% | ||
| Q2 24 | — | -20.9% | ||
| Q1 24 | — | -9.7% |
| Q4 25 | — | 5.0% | ||
| Q3 25 | — | 8.6% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 2.9% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | — | 2.83× | ||
| Q3 25 | — | 1.72× | ||
| Q2 25 | -6.24× | 1.61× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 6.11× | ||
| Q3 24 | — | 1.34× | ||
| Q2 24 | — | -0.68× | ||
| Q1 24 | — | -0.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABUS
Segment breakdown not available.
CODA
| Segment Reporting | $3.1M | 42% |
| Transferred At Point In Time | $1.8M | 24% |
| Precision Acoustics Limited | $1.3M | 18% |
| Other | $1.1M | 15% |
